UBALD2: A Potential Drug Target in Cellular Processes (G283991)
UBALD2: A Potential Drug Target in Cellular Processes
UBALD2 (Ubiquity Domain-Linked Abstracting and Retrieval) is a protein that is expressed in various tissues of the human body. It is a member of the superfamily of proteins known as the ubiquitin-like domains (UBD) and is characterized by the presence of a hydrophobic domain, a putative transmembrane region, and a cytoplasmic tail. UBALD2 has been shown to play a role in a variety of cellular processes, including cell adhesion, migration, and transcriptional regulation.
One of the most promising aspects of UBALD2 is its potential as a drug target. The ability of UBALD2 to interact with a variety of molecules, including transcription factors, cytokines, and signaling proteins, makes it an attractive target for the development of new therapeutic agents.
UBALD2 has been shown to interact with several transcription factors, including NF-kappa-B, AP-1, and STAT3. These interactions play a role in the regulation of cellular processes such as cell adhesion, migration, and transcriptional regulation. For example, UBALD2 has been shown to interact with NF-kappa-B and to regulate the expression of genes involved in cell adhesion and migration.
In addition to its role in cell adhesion and migration, UBALD2 has also been shown to play a role in the regulation of inflammation and immune response. For example, UBALD2 has been shown to interact with the protein PD-L1 and to regulate the production of immune cells.
UBALD2 has also been shown to play a role in the regulation of metabolism and cellular signaling pathways. For example, UBALD2 has been shown to interact with the protein SIRT1 and to regulate the expression of genes involved in cellular signaling pathways.
In conclusion, UBALD2 is a protein that has been shown to play a role in a variety of cellular processes, including cell adhesion, migration, and transcriptional regulation. Its potential as a drug target makes it an attractive target for the development of new therapeutic agents. Further research is needed to fully understand the role of UBALD2 in cellular processes and to develop effective therapies based on its interactions with other molecules.
Protein Name: UBA Like Domain Containing 2
More Common Targets
UBAP1 | UBAP1L | UBAP2 | UBAP2L | UBASH3A | UBASH3B | UBB | UBBP1 | UBBP2 | UBBP4 | UBC | UBD | UBDP1 | UBE2A | UBE2B | UBE2C | UBE2CP3 | UBE2CP4 | UBE2D1 | UBE2D2 | UBE2D3 | UBE2D3P1 | UBE2D4 | UBE2DNL | UBE2E1 | UBE2E2 | UBE2E3 | UBE2F | UBE2F-SCLY | UBE2FP1 | UBE2G1 | UBE2G2 | UBE2H | UBE2HP1 | UBE2I | UBE2J1 | UBE2J2 | UBE2K | UBE2L1 | UBE2L3 | UBE2L6 | UBE2M | UBE2MP1 | UBE2N | UBE2NL | UBE2O | UBE2Q1 | UBE2Q2 | UBE2Q2P1 | UBE2Q2P11 | UBE2Q2P13 | UBE2Q2P16 | UBE2Q2P2 | UBE2QL1 | UBE2R2 | UBE2R2-AS1 | UBE2S | UBE2T | UBE2U | UBE2V1 | UBE2V1P2 | UBE2V1P9 | UBE2V2 | UBE2V2P1 | UBE2W | UBE2Z | UBE3A | UBE3B | UBE3C | UBE3D | UBE4A | UBE4B | UBFD1 | UBIAD1 | Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 | Ubiquitin E3 ligase (ASB2, TCEB1, TCEB2, CUL5, RNF7) complex | UBL3 | UBL4A | UBL4B | UBL5 | UBL5P3 | UBL7 | UBL7-DT | UBLCP1 | UBN1 | UBN2 | UBOX5 | UBOX5-AS1 | UBP1 | UBQLN1 | UBQLN1-AS1 | UBQLN2 | UBQLN3 | UBQLN4 | UBQLNL | UBR1 | UBR2 | UBR3 | UBR4 | UBR5